

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 6.31355479 |
| 2 | cytidine catabolic process (GO:0006216) | 6.31355479 |
| 3 | cytidine deamination (GO:0009972) | 6.31355479 |
| 4 | DNA deamination (GO:0045006) | 6.03964256 |
| 5 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.42145413 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.26763964 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.12963084 |
| 8 | actin nucleation (GO:0045010) | 4.47167428 |
| 9 | immunoglobulin mediated immune response (GO:0016064) | 4.28253506 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 4.06165438 |
| 11 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.75655572 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.73830425 |
| 13 | negative regulation of T cell apoptotic process (GO:0070233) | 3.68287241 |
| 14 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.63324776 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.57122314 |
| 16 | positive thymic T cell selection (GO:0045059) | 3.56243347 |
| 17 | B cell mediated immunity (GO:0019724) | 3.52968795 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.52915252 |
| 19 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.42672810 |
| 20 | sequestering of actin monomers (GO:0042989) | 3.41482005 |
| 21 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.38422519 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38251661 |
| 23 | regulation of activation of Janus kinase activity (GO:0010533) | 3.26379463 |
| 24 | regulation of chronic inflammatory response (GO:0002676) | 3.25150597 |
| 25 | positive T cell selection (GO:0043368) | 3.21106140 |
| 26 | response to interferon-beta (GO:0035456) | 3.20506448 |
| 27 | purine nucleotide salvage (GO:0032261) | 3.18097420 |
| 28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.17232827 |
| 29 | T cell costimulation (GO:0031295) | 3.17046740 |
| 30 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.16917434 |
| 31 | T cell migration (GO:0072678) | 3.15002918 |
| 32 | eosinophil chemotaxis (GO:0048245) | 3.13894021 |
| 33 | lymphocyte costimulation (GO:0031294) | 3.13743952 |
| 34 | regulation of B cell differentiation (GO:0045577) | 3.11967076 |
| 35 | positive regulation of lymphocyte migration (GO:2000403) | 3.09764558 |
| 36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.06959715 |
| 37 | regulation of regulatory T cell differentiation (GO:0045589) | 3.03747966 |
| 38 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.00202721 |
| 39 | negative regulation of viral genome replication (GO:0045071) | 2.99459517 |
| 40 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.99235553 |
| 41 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.99235553 |
| 42 | regulation of interleukin-8 secretion (GO:2000482) | 2.98126458 |
| 43 | platelet dense granule organization (GO:0060155) | 2.96929123 |
| 44 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.96224948 |
| 45 | negative T cell selection (GO:0043383) | 2.96057893 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 2.94763806 |
| 47 | mature B cell differentiation involved in immune response (GO:0002313) | 2.91914609 |
| 48 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.88628560 |
| 49 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.87211219 |
| 50 | ATP synthesis coupled proton transport (GO:0015986) | 2.87211219 |
| 51 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.87066479 |
| 52 | eosinophil migration (GO:0072677) | 2.84229897 |
| 53 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.83581252 |
| 54 | positive regulation of T cell migration (GO:2000406) | 2.82737653 |
| 55 | negative regulation by host of viral transcription (GO:0043922) | 2.79397169 |
| 56 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.77279568 |
| 57 | granulocyte activation (GO:0036230) | 2.76448427 |
| 58 | regulation of antigen processing and presentation (GO:0002577) | 2.75386295 |
| 59 | neutrophil activation involved in immune response (GO:0002283) | 2.75044659 |
| 60 | deoxyribonucleotide catabolic process (GO:0009264) | 2.74148286 |
| 61 | respiratory electron transport chain (GO:0022904) | 2.73547461 |
| 62 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.73254609 |
| 63 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.71859015 |
| 64 | T cell receptor signaling pathway (GO:0050852) | 2.71531423 |
| 65 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.71275055 |
| 66 | regulation of T cell apoptotic process (GO:0070232) | 2.70450599 |
| 67 | macrophage chemotaxis (GO:0048246) | 2.70361257 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.70325965 |
| 69 | autophagic vacuole fusion (GO:0000046) | 2.69839508 |
| 70 | electron transport chain (GO:0022900) | 2.69590893 |
| 71 | mast cell activation (GO:0045576) | 2.69531745 |
| 72 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.67304470 |
| 73 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.66949284 |
| 74 | positive regulation of defense response to virus by host (GO:0002230) | 2.66637664 |
| 75 | lymphocyte chemotaxis (GO:0048247) | 2.66338055 |
| 76 | deoxyribose phosphate catabolic process (GO:0046386) | 2.65940705 |
| 77 | iron-sulfur cluster assembly (GO:0016226) | 2.64874414 |
| 78 | metallo-sulfur cluster assembly (GO:0031163) | 2.64874414 |
| 79 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.64813556 |
| 80 | regulation of tolerance induction (GO:0002643) | 2.64601543 |
| 81 | neutrophil activation (GO:0042119) | 2.64048395 |
| 82 | positive regulation of tolerance induction (GO:0002645) | 2.63201618 |
| 83 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.63075199 |
| 84 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.62014010 |
| 85 | protein neddylation (GO:0045116) | 2.61623024 |
| 86 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.60344069 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59595237 |
| 88 | regulation of T cell migration (GO:2000404) | 2.59088302 |
| 89 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.58724554 |
| 90 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.58320470 |
| 91 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.57797482 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.56451748 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.55433930 |
| 94 | positive regulation of interleukin-17 production (GO:0032740) | 2.54512152 |
| 95 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.54238942 |
| 96 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.52401786 |
| 97 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.51277538 |
| 98 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.51277538 |
| 99 | regulation of monocyte chemotaxis (GO:0090025) | 2.51058151 |
| 100 | purine-containing compound salvage (GO:0043101) | 2.49691846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.91634013 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.45130195 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.93586072 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.67406222 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28074521 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.20666669 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.96321039 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.76380949 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.72020147 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.51899107 |
| 11 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.50552311 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.40453331 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34621269 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13930066 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.10287899 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01435572 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00378675 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.96522050 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91300004 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88966400 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85780732 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80300143 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78390437 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.75664814 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.74901095 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.72524706 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.69848774 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69417310 |
| 29 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68053090 |
| 30 | GATA3_26560356_Chip-Seq_TH2_Human | 1.67261222 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.63059187 |
| 32 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.61077286 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.58230001 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56158139 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53790920 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50846209 |
| 37 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.50092329 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.46894558 |
| 39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45525591 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44185741 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.39500355 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34623869 |
| 43 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.33436073 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.31709497 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29254054 |
| 46 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28446797 |
| 47 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.24568967 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.24382307 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22690017 |
| 50 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20675268 |
| 51 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.19219569 |
| 52 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.16320336 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16085214 |
| 54 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.15934564 |
| 55 | AR_20517297_ChIP-Seq_VCAP_Human | 1.15596663 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15271890 |
| 57 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14710622 |
| 58 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.11817127 |
| 59 | P300_27268052_Chip-Seq_Bcells_Human | 1.11750466 |
| 60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10265725 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.07865217 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.07865217 |
| 63 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.07020121 |
| 64 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06806142 |
| 65 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06600822 |
| 66 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.06066193 |
| 67 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05046835 |
| 68 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05016012 |
| 69 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.04468129 |
| 70 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04465287 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.04270744 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.02742789 |
| 73 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00669344 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 0.98820276 |
| 75 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.98275742 |
| 76 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98261020 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98261020 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98199897 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.97970468 |
| 80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97900012 |
| 81 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96668039 |
| 82 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96488984 |
| 83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95613059 |
| 84 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92382066 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91132283 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90977924 |
| 87 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.90355148 |
| 88 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88917520 |
| 89 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.88833506 |
| 90 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88590659 |
| 91 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.88173981 |
| 92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.87075641 |
| 93 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86607419 |
| 94 | NCOR_22424771_ChIP-Seq_293T_Human | 0.86294669 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85260525 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84570797 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84101130 |
| 98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83881962 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82426375 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80526360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.77781196 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.19989957 |
| 3 | MP0009785_altered_susceptibility_to | 3.53778520 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.15889791 |
| 5 | MP0005000_abnormal_immune_tolerance | 2.86051474 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.77115540 |
| 7 | MP0003724_increased_susceptibility_to | 2.65443055 |
| 8 | MP0001800_abnormal_humoral_immune | 2.50687079 |
| 9 | MP0005025_abnormal_response_to | 2.50669552 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.43266179 |
| 11 | MP0002723_abnormal_immune_serum | 2.36316646 |
| 12 | MP0006082_CNS_inflammation | 2.34408998 |
| 13 | MP0009333_abnormal_splenocyte_physiolog | 2.26561165 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.21392771 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.20070826 |
| 16 | MP0001819_abnormal_immune_cell | 2.17189145 |
| 17 | MP0001790_abnormal_immune_system | 2.15937935 |
| 18 | MP0005387_immune_system_phenotype | 2.15937935 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.12836436 |
| 20 | MP0003436_decreased_susceptibility_to | 2.02916403 |
| 21 | MP0009764_decreased_sensitivity_to | 2.02874231 |
| 22 | MP0002419_abnormal_innate_immunity | 1.91939734 |
| 23 | MP0000372_irregular_coat_pigmentation | 1.78181408 |
| 24 | MP0000685_abnormal_immune_system | 1.76074343 |
| 25 | MP0002398_abnormal_bone_marrow | 1.72234223 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.70918282 |
| 27 | MP0000716_abnormal_immune_system | 1.68767101 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.64567367 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.63354334 |
| 30 | MP0002405_respiratory_system_inflammati | 1.63019254 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 1.61806501 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.59638366 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.58215637 |
| 34 | MP0001873_stomach_inflammation | 1.53960603 |
| 35 | MP0003866_abnormal_defecation | 1.50449078 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.48074637 |
| 37 | MP0008469_abnormal_protein_level | 1.44104574 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.37783904 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.35678159 |
| 40 | MP0002429_abnormal_blood_cell | 1.34792055 |
| 41 | MP0004147_increased_porphyrin_level | 1.34254681 |
| 42 | MP0002006_tumorigenesis | 1.32616919 |
| 43 | MP0002722_abnormal_immune_system | 1.31398638 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.29124005 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.29124005 |
| 46 | MP0009379_abnormal_foot_pigmentation | 1.26221032 |
| 47 | MP0003075_altered_response_to | 1.25778870 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.23988881 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.23351839 |
| 50 | MP0003646_muscle_fatigue | 1.22650094 |
| 51 | MP0001905_abnormal_dopamine_level | 1.22051437 |
| 52 | MP0009763_increased_sensitivity_to | 1.21812410 |
| 53 | MP0008872_abnormal_physiological_respon | 1.19751590 |
| 54 | MP0009278_abnormal_bone_marrow | 1.18465552 |
| 55 | MP0001853_heart_inflammation | 1.18334210 |
| 56 | MP0008995_early_reproductive_senescence | 1.15989206 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.15480987 |
| 58 | MP0002102_abnormal_ear_morphology | 1.12993743 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.11911903 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 1.11731018 |
| 61 | MP0005410_abnormal_fertilization | 1.10555033 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.08424757 |
| 63 | MP0000343_altered_response_to | 1.07100825 |
| 64 | MP0001764_abnormal_homeostasis | 1.01168742 |
| 65 | MP0003195_calcinosis | 1.00946491 |
| 66 | MP0003186_abnormal_redox_activity | 1.00394084 |
| 67 | MP0002653_abnormal_ependyma_morphology | 0.98689400 |
| 68 | MP0002095_abnormal_skin_pigmentation | 0.97669360 |
| 69 | MP0003448_altered_tumor_morphology | 0.97593166 |
| 70 | MP0003303_peritoneal_inflammation | 0.96905326 |
| 71 | MP0004947_skin_inflammation | 0.96432674 |
| 72 | MP0005166_decreased_susceptibility_to | 0.96138053 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 0.94636350 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 0.92406389 |
| 75 | MP0002132_abnormal_respiratory_system | 0.91135811 |
| 76 | MP0002933_joint_inflammation | 0.90009088 |
| 77 | MP0005253_abnormal_eye_physiology | 0.87679260 |
| 78 | MP0000703_abnormal_thymus_morphology | 0.87314403 |
| 79 | MP0003011_delayed_dark_adaptation | 0.86283397 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 0.84593503 |
| 81 | MP0008004_abnormal_stomach_pH | 0.83766695 |
| 82 | MP0001919_abnormal_reproductive_system | 0.81768083 |
| 83 | MP0009643_abnormal_urine_homeostasis | 0.80750406 |
| 84 | MP0001663_abnormal_digestive_system | 0.78975041 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.78940377 |
| 86 | MP0001968_abnormal_touch/_nociception | 0.78201956 |
| 87 | MP0009697_abnormal_copulation | 0.77511602 |
| 88 | MP0005360_urolithiasis | 0.76188287 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.75806690 |
| 90 | MP0000858_altered_metastatic_potential | 0.73570748 |
| 91 | MP0002139_abnormal_hepatobiliary_system | 0.72749434 |
| 92 | MP0002736_abnormal_nociception_after | 0.68796735 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.68629592 |
| 94 | MP0004142_abnormal_muscle_tone | 0.68286105 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.67965192 |
| 96 | MP0003786_premature_aging | 0.67294575 |
| 97 | MP0001542_abnormal_bone_strength | 0.66779554 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.65799779 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.64555176 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.64476711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.82093857 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.44327838 |
| 3 | T lymphocytopenia (HP:0005403) | 3.73101188 |
| 4 | IgG deficiency (HP:0004315) | 3.64822250 |
| 5 | Mitochondrial inheritance (HP:0001427) | 3.62781297 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 3.60557110 |
| 7 | Abnormality of the prostate (HP:0008775) | 3.59821797 |
| 8 | Abnormality of B cell number (HP:0010975) | 3.58558163 |
| 9 | Abnormality of T cell number (HP:0011839) | 3.53303816 |
| 10 | B lymphocytopenia (HP:0010976) | 3.51389755 |
| 11 | Hypoproteinemia (HP:0003075) | 3.48103539 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.41950045 |
| 13 | Stomatitis (HP:0010280) | 3.39006270 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.38912072 |
| 15 | Hepatocellular necrosis (HP:0001404) | 3.35437121 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.25666762 |
| 17 | Obstructive lung disease (HP:0006536) | 3.23493409 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.23493409 |
| 19 | Increased IgM level (HP:0003496) | 3.07918322 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 3.04608194 |
| 21 | Agammaglobulinemia (HP:0004432) | 3.04360219 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.02491086 |
| 23 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.02491086 |
| 24 | Hepatic necrosis (HP:0002605) | 3.01395251 |
| 25 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.95602035 |
| 26 | Petechiae (HP:0000967) | 2.90983590 |
| 27 | Increased CSF lactate (HP:0002490) | 2.89183344 |
| 28 | Increased muscle lipid content (HP:0009058) | 2.88049578 |
| 29 | Combined immunodeficiency (HP:0005387) | 2.87165152 |
| 30 | Meningitis (HP:0001287) | 2.85254268 |
| 31 | 3-Methylglutaconic aciduria (HP:0003535) | 2.84761677 |
| 32 | Thyroiditis (HP:0100646) | 2.83523924 |
| 33 | Acute encephalopathy (HP:0006846) | 2.82704753 |
| 34 | Progressive macrocephaly (HP:0004481) | 2.79089151 |
| 35 | Abnormality of T cells (HP:0002843) | 2.78763709 |
| 36 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.77016767 |
| 37 | Renal Fanconi syndrome (HP:0001994) | 2.70777691 |
| 38 | Congenital stationary night blindness (HP:0007642) | 2.66085871 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.65767717 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.59705397 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 2.58098831 |
| 42 | Myositis (HP:0100614) | 2.53489322 |
| 43 | Abolished electroretinogram (ERG) (HP:0000550) | 2.53090841 |
| 44 | Encephalitis (HP:0002383) | 2.52089419 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.50068200 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.48111351 |
| 47 | Leukocytosis (HP:0001974) | 2.42302593 |
| 48 | Chronic diarrhea (HP:0002028) | 2.37886100 |
| 49 | Decreased central vision (HP:0007663) | 2.37039424 |
| 50 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.36786913 |
| 51 | Vasculitis (HP:0002633) | 2.34632553 |
| 52 | Increased hepatocellular lipid droplets (HP:0006565) | 2.31323681 |
| 53 | Cerebral edema (HP:0002181) | 2.30487388 |
| 54 | Cerebral palsy (HP:0100021) | 2.28688314 |
| 55 | Epistaxis (HP:0000421) | 2.28408665 |
| 56 | Eosinophilia (HP:0001880) | 2.28242135 |
| 57 | Purpura (HP:0000979) | 2.23571023 |
| 58 | Lipid accumulation in hepatocytes (HP:0006561) | 2.23226385 |
| 59 | Exertional dyspnea (HP:0002875) | 2.22544070 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.21078490 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.20242292 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.20242292 |
| 63 | Gangrene (HP:0100758) | 2.19773023 |
| 64 | Recurrent viral infections (HP:0004429) | 2.19578211 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.19354597 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.18989011 |
| 67 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.18533031 |
| 68 | Recurrent bronchitis (HP:0002837) | 2.18101054 |
| 69 | Hemoptysis (HP:0002105) | 2.15540263 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.14930821 |
| 71 | Optic disc pallor (HP:0000543) | 2.12209998 |
| 72 | Recurrent abscess formation (HP:0002722) | 2.11467060 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.10399117 |
| 74 | Attenuation of retinal blood vessels (HP:0007843) | 2.09224766 |
| 75 | Chest pain (HP:0100749) | 2.08777395 |
| 76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08101228 |
| 77 | Granulocytopenia (HP:0001913) | 2.06101572 |
| 78 | Lactic acidosis (HP:0003128) | 2.03500793 |
| 79 | Dicarboxylic aciduria (HP:0003215) | 2.03075127 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03075127 |
| 81 | Reduced antithrombin III activity (HP:0001976) | 2.02970050 |
| 82 | Abnormality of male internal genitalia (HP:0000022) | 2.01486024 |
| 83 | Type I transferrin isoform profile (HP:0003642) | 2.01175297 |
| 84 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.99085379 |
| 85 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.97440820 |
| 86 | Joint swelling (HP:0001386) | 1.96012581 |
| 87 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95870315 |
| 88 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94817034 |
| 89 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94817034 |
| 90 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94817034 |
| 91 | Severe visual impairment (HP:0001141) | 1.94418386 |
| 92 | Pancytopenia (HP:0001876) | 1.93403681 |
| 93 | Optic neuritis (HP:0100653) | 1.91686321 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 1.91686321 |
| 95 | Gingival bleeding (HP:0000225) | 1.91551096 |
| 96 | Abnormality of the pleura (HP:0002103) | 1.90744100 |
| 97 | Increased serum lactate (HP:0002151) | 1.90595151 |
| 98 | Pulmonary fibrosis (HP:0002206) | 1.90317400 |
| 99 | Amyotrophic lateral sclerosis (HP:0007354) | 1.89600231 |
| 100 | Recurrent bacterial skin infections (HP:0005406) | 1.88609551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.64554148 |
| 2 | TESK2 | 4.57160395 |
| 3 | TXK | 4.35778420 |
| 4 | BCKDK | 3.18837336 |
| 5 | TAOK3 | 2.77948710 |
| 6 | MAP4K1 | 2.54802180 |
| 7 | SCYL2 | 2.34743382 |
| 8 | ADRBK2 | 2.13015523 |
| 9 | BMPR2 | 2.02171710 |
| 10 | MAP4K2 | 2.01872922 |
| 11 | MAP3K12 | 1.99641298 |
| 12 | VRK2 | 1.96298128 |
| 13 | SYK | 1.83113988 |
| 14 | KIT | 1.80311905 |
| 15 | ITK | 1.77800865 |
| 16 | TEC | 1.77324181 |
| 17 | ZAK | 1.76589033 |
| 18 | CDK19 | 1.76153158 |
| 19 | MAP3K11 | 1.74260997 |
| 20 | TESK1 | 1.73303833 |
| 21 | PIM2 | 1.65041983 |
| 22 | CSF1R | 1.64209913 |
| 23 | GRK6 | 1.58719020 |
| 24 | GRK1 | 1.52414467 |
| 25 | IKBKB | 1.52316776 |
| 26 | GRK7 | 1.50984577 |
| 27 | FES | 1.50859335 |
| 28 | IKBKE | 1.44598949 |
| 29 | TBK1 | 1.34434949 |
| 30 | LIMK1 | 1.29185923 |
| 31 | TLK1 | 1.29052800 |
| 32 | BTK | 1.26306265 |
| 33 | MST4 | 1.23183744 |
| 34 | FLT3 | 1.21029733 |
| 35 | MYLK | 1.20834127 |
| 36 | JAK3 | 1.17478000 |
| 37 | LYN | 1.15988413 |
| 38 | TNK2 | 1.15262431 |
| 39 | NME2 | 1.14167032 |
| 40 | LCK | 1.13440423 |
| 41 | DAPK1 | 1.11069614 |
| 42 | MATK | 1.10880271 |
| 43 | NUAK1 | 1.07513998 |
| 44 | RIPK4 | 1.05827443 |
| 45 | VRK1 | 1.02045256 |
| 46 | ZAP70 | 1.00815475 |
| 47 | CSK | 0.97779232 |
| 48 | PRKCQ | 0.92391842 |
| 49 | BLK | 0.88694798 |
| 50 | PIM1 | 0.83156609 |
| 51 | PIK3CG | 0.81662905 |
| 52 | PINK1 | 0.81601977 |
| 53 | MUSK | 0.79883058 |
| 54 | BMPR1B | 0.74497307 |
| 55 | RPS6KA5 | 0.70634665 |
| 56 | ABL2 | 0.68722896 |
| 57 | TAOK2 | 0.66709997 |
| 58 | MAP2K7 | 0.64284767 |
| 59 | DAPK3 | 0.63465354 |
| 60 | INSRR | 0.60926653 |
| 61 | DAPK2 | 0.58322147 |
| 62 | STK16 | 0.57911142 |
| 63 | TIE1 | 0.57422215 |
| 64 | PKN1 | 0.56392892 |
| 65 | ARAF | 0.55715094 |
| 66 | MAPKAPK3 | 0.53964260 |
| 67 | MAP3K5 | 0.51515832 |
| 68 | OXSR1 | 0.51326028 |
| 69 | RPS6KA4 | 0.50981949 |
| 70 | CSNK1G3 | 0.49688459 |
| 71 | TYK2 | 0.49327200 |
| 72 | ADRBK1 | 0.48321927 |
| 73 | IGF1R | 0.48272919 |
| 74 | FYN | 0.47837384 |
| 75 | HCK | 0.45526839 |
| 76 | PRKCA | 0.42838231 |
| 77 | PRKCD | 0.38672528 |
| 78 | OBSCN | 0.38660861 |
| 79 | ABL1 | 0.37511101 |
| 80 | MAP3K14 | 0.36807402 |
| 81 | GRK5 | 0.36544108 |
| 82 | PRKACA | 0.35277875 |
| 83 | CCNB1 | 0.32439220 |
| 84 | JAK2 | 0.32262699 |
| 85 | ROCK1 | 0.32072325 |
| 86 | MARK3 | 0.31914554 |
| 87 | ILK | 0.31829984 |
| 88 | DYRK2 | 0.31350225 |
| 89 | MAP2K6 | 0.30737199 |
| 90 | CSNK2A1 | 0.29757622 |
| 91 | PAK1 | 0.29482974 |
| 92 | FRK | 0.28882775 |
| 93 | IRAK4 | 0.28414647 |
| 94 | PRKCE | 0.26905484 |
| 95 | CDK8 | 0.26074451 |
| 96 | PRKG2 | 0.25938357 |
| 97 | ERBB3 | 0.25850834 |
| 98 | CSNK1G2 | 0.25470647 |
| 99 | CHUK | 0.25271201 |
| 100 | AURKA | 0.23023670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.93339634 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.90758398 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.88629408 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.79174968 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.77359686 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.27722864 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.98117200 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.97649081 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.89431788 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.79988361 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.63917399 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.36808647 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.24957522 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.18974327 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04211936 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.97218817 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.74581785 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56082105 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.49363974 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44828198 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.42456638 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34464974 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25939360 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18167272 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15365282 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13636481 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.12282332 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.10082672 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07885799 |
| 30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07061586 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.07001873 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04640537 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03814792 |
| 34 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.02011831 |
| 35 | Malaria_Homo sapiens_hsa05144 | 0.97475884 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96902815 |
| 37 | RNA polymerase_Homo sapiens_hsa03020 | 0.95854585 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94944390 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92612439 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89698948 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87430275 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 0.81288909 |
| 43 | Measles_Homo sapiens_hsa05162 | 0.76964036 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 0.74759569 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74223453 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73500919 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72847550 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 0.71435618 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 0.70712703 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.70670854 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69087952 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68521776 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.68421369 |
| 54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65198223 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63538970 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62983147 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61634905 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61536753 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61371112 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 0.60382502 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60307027 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59583280 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58149298 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56900783 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52600332 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.52248212 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47859570 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.47834350 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47442590 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46402924 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45488656 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45323593 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44803411 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43486185 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42062874 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.42020175 |
| 77 | Purine metabolism_Homo sapiens_hsa00230 | 0.41910413 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41438716 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39685567 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39549750 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39242860 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38309524 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38243011 |
| 84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38206751 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37227452 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37223804 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35979413 |
| 88 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32980820 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30740360 |
| 90 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29575775 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29368786 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28054169 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26364260 |
| 94 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.26267433 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.26082319 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.26002276 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23848573 |
| 98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.22728568 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.19878323 |
| 100 | Base excision repair_Homo sapiens_hsa03410 | 0.18653594 |

